: Cardiovascular diseases represent a major cause of morbidity and mortality, necessitating research to improve diagnostics, and to discover and test novel preventive and curative therapies. All of which warrant experimental models that recapitulate human disease. The translation of basic science results to clinical practice is a challenging task. In particular for complex conditions such as cardiovascular diseases, which often result from multiple risk factors and co-morbidities. This difficulty might lead some individuals to question the value of animal research, citing the translational 'valley of death', which largely reflects the fact that studies in rodents are difficult to translate to humans. This is also influenced by the fact that new, human-derived in vitro models can recapitulate aspects of disease processes. However, it would be a mistake to think that animal models cannot provide a vital step in the translational pathway as they do provide important pathophysiological insights into disease mechanisms particularly on a organ and systemic level. While stem cell-derived human models have the potential to become key in testing toxicity and effectiveness of new drugs, we need to be realistic, and carefully validate all new human-like disease models. In this position paper, we highlight recent advances in trying to reduce the number of animals for cardiovascular research ranging from stem cell-derived models to in situ modelling of heart properties, bioinformatic models based on large datasets, and improved current animal models, which show clinically relevant characteristics observed in patients with a cardiovascular disease. We aim to provide a guide to help researchers in their experimental design to translate bench findings to clinical routine taking the replacement, reduction and refinement (3R) as a guiding concept.

Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC Working Group on Cellular Biology of the Heart / van der Velden, Jolanda; Asselbergs, Folkert W; Bakkers, Jeroen; Batkai, Sandor; Bertrand, Luc; Bezzina, Connie R; Bot, Ilze; Brundel, Bianca; Carrier, Lucie; Chamuleau, Steven; Ciccarelli, Michele; Dawson, Dana; Davidson, Sean M; Dendorfer, Andreas; Duncker, Dirk J; Eschenhagen, Thomas; Fabritz, Larissa; Falcão-Pires, Ines; Ferdinandy, Péter; Giacca, Mauro; Girao, Henrique; Gollmann-Tepeköylü, Can; Gyongyosi, Mariann; Guzik, Tomasz J; Hamdani, Nazha; Heymans, Stephane; Hilfiker, Andres; Hilfiker-Kleiner, Denise; Hoekstra, Alfons G; Hulot, Jean-Sébastien; Kuster, Diederik W D; van Laake, Linda W; Lecour, Sandrine; Leiner, Tim; Linke, Wolfgang A; Lumens, Joost; Lutgens, Esther; Madonna, Rosalinda; Maegdefessel, Lars; Mayr, Manuel; van der Meer, Peter; Passier, Robert; Perbellini, Filippo; Perrino, Cinzia; Pesce, Maurizio; Priori, Silvia; Remme, Carol Ann; Rosenhahn, Bodo; Schotten, Ulrich; Schulz, Rainer; Sipido, Karin; Sluijter, Joost P G; van Steenbeek, Frank; Steffens, Sabine; Terracciano, Cesare M; Tocchetti, Carlo Gabriele; Vlasman, Patricia; Yeung, Kak Khee; Zacchigna, Serena; Zwaagman, Dayenne; Thum, Thomas. - In: CARDIOVASCULAR RESEARCH. - ISSN 0008-6363. - (2022). [10.1093/cvr/cvab370]

Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC Working Group on Cellular Biology of the Heart

Ciccarelli, Michele;Heymans, Stephane;Perrino, Cinzia;Tocchetti, Carlo Gabriele;Zacchigna, Serena;
2022

Abstract

: Cardiovascular diseases represent a major cause of morbidity and mortality, necessitating research to improve diagnostics, and to discover and test novel preventive and curative therapies. All of which warrant experimental models that recapitulate human disease. The translation of basic science results to clinical practice is a challenging task. In particular for complex conditions such as cardiovascular diseases, which often result from multiple risk factors and co-morbidities. This difficulty might lead some individuals to question the value of animal research, citing the translational 'valley of death', which largely reflects the fact that studies in rodents are difficult to translate to humans. This is also influenced by the fact that new, human-derived in vitro models can recapitulate aspects of disease processes. However, it would be a mistake to think that animal models cannot provide a vital step in the translational pathway as they do provide important pathophysiological insights into disease mechanisms particularly on a organ and systemic level. While stem cell-derived human models have the potential to become key in testing toxicity and effectiveness of new drugs, we need to be realistic, and carefully validate all new human-like disease models. In this position paper, we highlight recent advances in trying to reduce the number of animals for cardiovascular research ranging from stem cell-derived models to in situ modelling of heart properties, bioinformatic models based on large datasets, and improved current animal models, which show clinically relevant characteristics observed in patients with a cardiovascular disease. We aim to provide a guide to help researchers in their experimental design to translate bench findings to clinical routine taking the replacement, reduction and refinement (3R) as a guiding concept.
2022
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC Working Group on Cellular Biology of the Heart / van der Velden, Jolanda; Asselbergs, Folkert W; Bakkers, Jeroen; Batkai, Sandor; Bertrand, Luc; Bezzina, Connie R; Bot, Ilze; Brundel, Bianca; Carrier, Lucie; Chamuleau, Steven; Ciccarelli, Michele; Dawson, Dana; Davidson, Sean M; Dendorfer, Andreas; Duncker, Dirk J; Eschenhagen, Thomas; Fabritz, Larissa; Falcão-Pires, Ines; Ferdinandy, Péter; Giacca, Mauro; Girao, Henrique; Gollmann-Tepeköylü, Can; Gyongyosi, Mariann; Guzik, Tomasz J; Hamdani, Nazha; Heymans, Stephane; Hilfiker, Andres; Hilfiker-Kleiner, Denise; Hoekstra, Alfons G; Hulot, Jean-Sébastien; Kuster, Diederik W D; van Laake, Linda W; Lecour, Sandrine; Leiner, Tim; Linke, Wolfgang A; Lumens, Joost; Lutgens, Esther; Madonna, Rosalinda; Maegdefessel, Lars; Mayr, Manuel; van der Meer, Peter; Passier, Robert; Perbellini, Filippo; Perrino, Cinzia; Pesce, Maurizio; Priori, Silvia; Remme, Carol Ann; Rosenhahn, Bodo; Schotten, Ulrich; Schulz, Rainer; Sipido, Karin; Sluijter, Joost P G; van Steenbeek, Frank; Steffens, Sabine; Terracciano, Cesare M; Tocchetti, Carlo Gabriele; Vlasman, Patricia; Yeung, Kak Khee; Zacchigna, Serena; Zwaagman, Dayenne; Thum, Thomas. - In: CARDIOVASCULAR RESEARCH. - ISSN 0008-6363. - (2022). [10.1093/cvr/cvab370]
File in questo prodotto:
File Dimensione Formato  
van der velden cvab370.pdf

solo utenti autorizzati

Licenza: Accesso privato/ristretto
Dimensione 1.68 MB
Formato Adobe PDF
1.68 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/866522
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 27
social impact